Target intelligence / Profile preview

Antioxidant pathways activation

Molecular classification
Other
01

Overview

Antioxidant pathways activation" is not a single molecule or receptor but rather refers to the coordinated induction and regulation of multiple cellular processes that protect cells from oxidative damage. These pathways are primarily regulated by transcription factors such as **Nrf2** in mammals, which upon activation translocate to the nucleus and bind to antioxidant response elements (ARE) in DNA, promoting the expression of various detoxifying and antioxidant enzymes including heme oxygenase 1 (HMOX1), NAD(P)H quinone dehydrogenase 1 (NQO1), glutathione S-transferases, among others. The purpose is to maintain redox homeostasis under conditions that generate reactive oxygen species—such as environmental toxins, inflammation, or mitochondrial dysfunction—and thereby prevent cellular injury or death. While these pathways are critical for normal physiology and protection against diseases like cancer and neurodegeneration, their chronic dysregulation can also contribute to pathology by supporting malignant cell survival or interfering with immune function[1][2][3][5]. Note: This entry does not correspond to a specific molecular target but rather describes a broad biological process involving many molecules; therefore it should not be considered a canonical therapeutic target itself.

Other names
Antioxidant response pathwayAntioxidant defense pathwaysARE pathway activation
02

Mechanism of action

Activation of transcription factors such as Nrf2, leading to upregulation of antioxidant genes via the antioxidant response element (ARE); Induction of cellular defense systems against reactive oxygen species and electrophiles

03

Biological functions

Cellular protection against oxidative stressRegulation of redox homeostasisInduction of detoxifying and antioxidant enzymesModulation of cell survival mechanisms
04

Disease associations

CancerNeurodegenerative diseaseCardiovascular diseaseInflammationOther diseases associated with oxidative stress (e.g., metabolic disorders)
05

Safety considerations

Overactivation may disrupt normal redox signaling or interfere with immune responses.Chronic activation could potentially support cancer cell survival in some contexts.
06

Interacting drugs

L-sulforaphane (activator)

2 more in the full profile.

07

Biomarkers

Expression levels of Nrf2 target genes (e.g., HMOX1, NQO1)

Beyond the preview

Go deeper on Antioxidant pathways activation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antioxidant pathways activation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call